Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche’s rheumatoid arthritis drug Actemra shows no benefit in COVID-19 pneumonia

June 18, 2020
Research and Development Actemra, COVID-19, Roche, coronavirus

Hope is waning around the efficacy of Roche’s Actemra (tocilizumab) following the release of results from an Italian study focusing …

News
national_guard

US Strategic National Stockpile now has 66 million hydroxychloroquine pills that cannot be used for coronavirus

June 18, 2020
Business Services COVID-19, chloroquine, coronavirus, hydroxychloroquine

The US is now sitting on a pile of 66 million anti-malaria pills, hydroxychloroquine and chloroquine, after they were removed …

News

FDA approval for Jazz and PharmaMar’s Zepzelca in metastatic small cell lung cancer

June 17, 2020
Manufacturing and Production, Research and Development, Sales and Marketing Cancer, FDA, PharmaMar, Zepzelca, jazz pharma, lung cancer

The FDA has awarded approval to Jazz Pharma and PharmaMar for Zepzelca (lurbinectedin) as a treatment for metastatic small cell …

News
type_2

New data from diabetes prevention programme shows a reduction of type 2 diabetes

June 17, 2020
Research and Development diabetes, type 2 diabetes

The Diabetes Prevention Program Outcomes Study (DPPOS) of 2,000 people showed a significant reduction in the participants’ risk of developing …

News
dexamethasone_matthew_horwoodgetty_images

Repurposed corticosteroid dexamethasone shown to reduce mortality in COVID-19 patients needing respiratory support

June 17, 2020
Research and Development COVID-19, University of Oxford, coronavirus, dexamethasone

The University of Oxford has unveiled exciting new data in the treatment of the novel coronavirus, with a randomised clinical …

News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

June 17, 2020
Research and Development COVID-19, coronavirus, coronavirus roundup

There is a fear of a second wave of coronavirus coming out of China, as the country reported its highest …

News

HPV vaccine approved by FDA to prevent throat cancer

June 17, 2020
Research and Development HPV, HPV STI, HPV vaccine

The HPV (human papillomavirus) vaccine Gardasil 9 has been approved by the FDA to prevent HPV-related genital tract, agnogenital infections …

News
sanofi

Sanofi drops €610m on new vaccine research and manufacturing sites in France

June 16, 2020
Manufacturing and Production COVID-19, Sanofi

The coronavirus outbreak has changed the way that the world prioritises healthcare resources, and lay bare just how unprepared many …

News
bhf

British Heart Foundation funding trial of experimental drug designed to prevent blood clots in coronavirus patients

June 16, 2020
Manufacturing and Production COVID-19, blood clots, coronavirus

The British Heart Foundation is funding a trial for a drug that could prevent life-threatening blood clots that have been …

News
nz

New Zealand no longer virus free after two new cases come from Britain

June 16, 2020
Manufacturing and Production COVID-19, New Zealand, coronavirus, pandemic

New Zealand has reported its first new case of coronavirus after two COVID-19 positive women arrived in the country from …

News
sinovac

Sinovac’s COVID-19 vaccine successfully generates immune response at Phase 1/2

June 16, 2020
Manufacturing and Production, Research and Development COVID-19, Sinovac, Vaccine, coronavirus, pharma

As more than 130 efforts to develop an effective vaccine against the novel coronavirus continue to roll on, Beijing-based firm …

News
fda

FDA revokes emergency approval of hydroxychloroquine and chloroquine

June 16, 2020
Manufacturing and Production COVID-19, chloroquine, coronavirus, hydroxychloroquine

The FDA has revoked its emergency approval of hydroxychloroquine and chloroquine due to health risks and a lack of effectiveness …

News
marc_p2

Mundipharma names Marc Princen as Global Chief Executive Officer

June 15, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, appointment

Marc Princen was revealed in mid-June as the new Global Chief Executive Officer (CEO) of the Mundipharma network, having taken …

Appointment
covid-19-4922384_640

COVID-19: UK and Europe life sciences regulatory developments

June 15, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Sidley Austin, coronavirus, pharma, regulation

Marie Manley, Partner, and Bethany Wise, Trainee Solicitor, at Sidley Austin look at UK and EU life sciences regulatory developments …

Feature
janssen_latest_logo_on_sign_closer

Tremfya’s skin clearance benefit lasts up to four years in plaque psoriasis patients, Janssen says

June 15, 2020
Research and Development, Sales and Marketing Janssen, Tremfya, plaque psoriasis

Janssen has revealed new data on its interleukin (IL)-23 inhibitor Tremfya (guselkumab) at the American Academy of Dermatology (AAD) virtual …

News
wuhan_citiy

Fear of a coronavirus second wave as China reports highest number of cases in months

June 15, 2020
Sales and Marketing COVID, COVID-19, coronavirus, pandemic

China reported its highest amount of coronavirus cases in months as a new outbreak has been linked to a food …

News
az_vaccinessssssssssss

AstraZeneca to supply Europe with 400 million COVID-19 vaccine doses

June 15, 2020
Sales and Marketing COVID, COVID-19, Vaccine, coronavirus

Multiple European governments have been involved in a deal with AstraZeneca to access a supply of the British drugmakers’ potential …

News

NICE greenlights Roche’s Rozlytrek for ROS1+ advanced non-small cell lung cancer

June 15, 2020
Sales and Marketing NICE, Roche, Rozlytrek, UK, lung cancer

Roche’s Rozlytrek (entrectinib) has secured recommendation for NHS use in England and Wales after NICE backed the drug in final …

News
mr_robot_cancer

AbbVie’s Venclexta plus azacitidine shows improved survival and remissions rates in leukaemia patients

June 15, 2020
Sales and Marketing AbbVie, leukaemia

AbbVie have announced positive results from its latest Phase 3 clinical trial where Venclexta plus azacitidine improved survival and remission …

News
shutterstock_138095450

Takeda jettisons non-core portfolio in Asia Pacific to Celltrion for a potential $278 million

June 12, 2020
Medical Communications, Sales and Marketing Takeda, celltrion, pharma, sale

Takeda continues its mission to reduce its debt in the wake of its $49 billion acquisition of Shire in January …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026